In view of the important role of cisplatin (CDDP) in cancer chemotherapy, the frequent occurrence of resistance to the drug is a major clinical problem. The main cause for unresponsiveness of a tumor to CDDP is thought to be cellular drug resistance, which may be caused by (1) a decreased uptake of
✦ LIBER ✦
Cisplatin resistance: Preclinical findings and clinical implications
✍ Scribed by Beate Köberle; Maja T. Tomicic; Svetlana Usanova; Bernd Kaina
- Book ID
- 113486758
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 555 KB
- Volume
- 1806
- Category
- Article
- ISSN
- 0304-419X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Resistance ot cisplatin and analogues: m
✍
Alexander Graeff; Robert J. C. Slebos; Sjoerd Rodenhuis
📂
Article
📅
1988
🏛
Springer
🌐
English
⚖ 932 KB
Cisplatin neuropathy: clinical course an
✍
Mauro LoMonaco; Margherita Milone; Anna Paola Batocchi; Luca Padua; Domenico Res
📂
Article
📅
1992
🏛
Springer
🌐
English
⚖ 615 KB
Cardiovascular Effects of Duloxetine: Pr
✍
M. Detke; S. Iyengar; J. Henck; F. Bymaster; J. Callaghan; M. Knadler; A. Chappe
📂
Article
📅
2006
🏛
American Society for Experimental NeuroTherapeutic
🌐
English
⚖ 52 KB
249. Neuroimmune interactions: Preclinic
✍
B. Leonard; M. Maes
📂
Article
📅
1998
🏛
Elsevier Science
🌐
English
⚖ 103 KB
Bridging the information gap: assimilati
✍
K. Preston; Harriet de Wit
📂
Article
📅
1997
🏛
Springer
🌐
English
⚖ 18 KB
Estrogen and cognition: Applying preclin
✍
Robert B. Gibbs; Rachel Gabor
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 109 KB
The effects of hormone replacement therapy on brain aging and cognition are an important public health issue, which, despite much research and debate, has not yet been resolved. In this Mini-Review, we describe how much of the clinical literature takes on new meaning when interpreted in light of rec